About
Our Medicine
Science
& Pipeline
Patients
Healthcare
Professionals
Investors
Company Overview
News Releases
Events & Presentations
Stock Information
Analyst Coverage
Governance
SEC Filings
Investor FAQs
Careers
About
Our Medicine
Science
& Pipeline
Patients
Healthcare
Professionals
Investors
Company Overview
News Releases
Events & Presentations
Stock Information
Analyst Coverage
Governance
SEC Filings
Investor FAQs
Careers
Rare
Resolve
.
Driving progress for people living with rare immune disorders
ABBEY
Living with Chronic Neutropenia
recent news
X4 Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
March 17, 2026
X4 Pharmaceuticals to Participate in a Fireside Chat at the Leerink Global Healthcare Conference
March 4, 2026
X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 2, 2026
More News
© Copyright 2026 X4 Pharmaceuticals. All Rights Reserved.
Terms of Use
|
Privacy
|
Compliance and Ethics
